Polaris Partners is a multistage venture capital firm based in Boston, New York, and San Francisco, focusing on healthcare and life sciences. Founded in 1996, it has invested in over 400 companies, achieving more than 100 exits.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Third-party rankings
| Ranking | Edition | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|
 Leading longevity investors by deal count (Longevity Investors Conference) | 2025 | #4 | No prior edition | C | Activity |
Polaris Partners is an investment firm founded in 1996, with offices in Boston, New York, and San Francisco. The organization focuses on backing transformational healthcare and biotech companies, leveraging nearly three decades of experience in the industry. Polaris invests in healthcare and life sciences sectors, specifically targeting innovative care delivery models, digital health, consumer-centric businesses, patient and provider solutions, data science, and analytics. The firm operates through two main funds: the Polaris Growth Fund, which supports profitable, founder-owned technology companies, and the Polaris Innovation Fund, which accelerates the commercial and therapeutic potential of early-stage academic research.
Polaris Partners invests in healthcare and life sciences sectors, specifically targeting innovative care delivery models, digital health, consumer-centric businesses, patient and provider solutions, data science, and analytics. Their life sciences investments include molecules and platforms, therapeutics, and genomics.
Polaris Partners adds value to portfolio companies by fostering innovation and building impactful companies through partnerships with entrepreneurs in early-stage academic research.
Polaris Partners focuses on healthcare and life sciences, as well as profitable B2B SaaS companies. They typically invest between $10 million and $50 million across seed, Series A, Series B, and growth equity stages.
Startups can reach out to Polaris Partners via email at partnership@polarispartners.com. A well-prepared pitch deck should include details about the business model, market opportunity, and team background.
Polaris Partners has a unique focus on healthcare and life sciences, with nearly 30 years of experience and a proven track record of over 400 backed companies and 50 therapies brought to market. Their growth fund specifically supports profitable SaaS founders seeking capital while retaining significant ownership.
Polaris primarily invests in North America and Asia, with a notable presence in Singapore through their 65LAB initiative, which facilitates cross-border biotech investments.
Polaris Partners actively supports its portfolio companies through mentorship, operational support, and strategic guidance, leveraging their extensive network and industry expertise to help founders succeed.
Polaris Partners typically invests between $10 million and $50 million, with a sweet spot around $20 million for their investments.
Organizations that do similar work to Polaris Partners.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorNueterra Capital is a Midwest-based venture capital firm that invests in early-stage healthcare and technology companies. Founded in 1997, it focuses on innovative firms in U.S. Emerging Markets.
InvestorOrbiMed is a healthcare-focused investment firm based in New York City, managing approximately $19 billion in assets. The firm invests across the healthcare spectrum, from early-stage startups to large multinational companies, with a focus on biopharmaceuticals and medical technologies.
Superscout Pro
Is this page right?Reviewed · How the research works